Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus ultrasound-guided stellate ganglion block for early sleep in elderly thoracoscopic surgery
ChiCTR2600120766Phase 4Not yet recruiting
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in bronchial carcinoma, Postoperative sleep disturbance (PSD) and postoperative pain (4 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoints: Pittsburgh Sleep Quality Index (PSQI) and Objective sleep quality by actigraphy (ActiLife 6 activity monitor). Planned start Mar 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
bronchial carcinomaPostoperative sleep disturbance (PSD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2600120766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120766.